TBK1 and Insulin resistance: Unlike intrathecal injection of TBK1-siRNA, systemic application of AMX improved insulin resistance in PDN mice (Fig. 6B); however, it exhibited no significant changes in blood glucose and body weight (Fig. 6C-D).